Gene Transfer Trials Should Require Sequencing Of Small Vectors - Cmte.
Executive Summary
FDA should require complete sequencing of gene transfer vectors up to 40 kilo bases in size before initiation of a Phase I gene transfer therapy clinical trial, the Biological Response Modifiers Advisory Committee recommended Nov. 16.